hanall biopharma 009420 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 009420 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2019.12 2020.03 2020.06 2020.09 2020.12 2021.03
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 842 918 1,085 948 261 221 226 221 232 199 232
O-profit 35 55 171 87 30 28 16 10 27 5 21
N-income 58 33 192 94 62 39 59 37 72 32 49
O-rate 4.2 6.0 15.8 8.6 11.5 12.7 7.1 4.5 11.6 2.5 8.9
N-rate 6.9 3.6 17.7 9.4 23.8 17.6 26.1 16.7 31.2 15.8 21.1
ROE 5.2 2.8 13.7 7.2 17.7 14.2 15.6 14.1 15.6 14.0 15.4
Debt-ratio 51.7 38.8 36.3 42.3 36.3 31.4 26.0 23.3 20.1 17.4 29.3
Quick-ratio 230.9 509.6 432.5 391.0 432.5 475.9 517.5 498.2 527.4 559.8 481.0
reserve-ratio 336.8 349.0 418.8 368.2 418.8 433.7 456.3 470.5 592.5 1,088.0 444.8
EPS 111 63 368 181 119 75 113 71 99 60 94
BPS 2,129 2,238 2,688 2,351 2,688 2,783 3,001 3,218 3,417 3,629 2,923
Dividends 0 0 0 0
2020-11-29
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ 79 %
High mid ~ 54 %
Mid ~ 29 %
Low mid ~ 4 %
Low price ~ -21 %
Indication price Range Current stock price Company score
54,075 W 54,075 W 45,328 W
45,328 W 45,328 W 36,582 W Evaluation
62,821 W 62,821 W~ 54,075 W
35,150 W
53.636,582 W 36,582 W 27,836 W
Low mid
Normal
27,836 W 27,836 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 39 3,125 688
27,836원
36,582원
45,328원
54,075원
62,821원
Low mid 35,150원
-21%
4.1%
29.%
53.8%
78.7%
-40%
-20%
0.%
20.%
40.%
60.%
80.%
100.%
0W
10,000W
20,000W
30,000W
40,000W
50,000W
60,000W
70,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
hanall biopharma
Gap
hanall biopharma

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 009420 Date
Period
Gap
(Indication /
stock)
Color
2020-11-29
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
35,150 W Low mid 56.6 Normal 8,800,000 W
Suggested Purchase
Amount 4,188,538 W
Number of stocks
purchased 119
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 62,821 W 62,821 W~ ~ 54,075 W 79 % -3,297,290 W -52
High mid 54,075 W 54,075 W ~ 45,328 W 54 % -2,255,083 W -42
Mid 45,328 W 45,328 W ~ 36,582 W 29 % -1,212,875 W -27
Low mid 36,582 W 36,582 W ~ 27,836 W 4 % -170,668 W -5
low price 27,836 W 27,836 W ~ 0 W -21 % 871,539 W 31
Stock price rise
probability score
A Sector 46.9 50.4 51.2 43.3 47.1 49.4
56.6B Sector 40.4 20.4 21.7 43.3 37.5 35.0
Total average
2020.07.03 2020.07.31 2020.08.31 2020.09.28 2020.10.30 2020.11.27
43.7 35.4 36.4 37.1 42.3 42.2
12 % -0 %
2020.07.31 2020.08.31 2020.09.28 2020.10.30 2020.11.27
Total of
increase rate
Total score
A Sector 7 % 2 % -18 % 8 % 5 %
-1 % 46.0B Sector -98 % 6 % 50 % -16 % -7 %
Total average -23 % 3 % 2 %
47
50 51
43
47 49
40
20 22
43
38 35
44
35 36 37
42 42
0
10
20
30
40
50
60
2020.07.03 2020.07.31 2020.08.31 2020.09.28 2020.10.30 2020.11.27
Stock price rise probability score
A sector
B sector
Total average
7% 2%
-18%
8% 5%
-98%
6%
50%
-16% -7%
-23%
3% 2%
12%
-0%
-150%
-100%
-50%
0%
50%
100%
2020.07.31 2020.08.31 2020.09.28 2020.10.30 2020.11.27
Increase rate of stock price rise
A sector
B sector
Total average
hanall biopharma

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report